Rigel Pharmaceuticals Inc (NASDAQ:RIGL)
| 1.35 Delayed Data As of Aug 09 |  -0.14 / -9.40%Today’s Change | 0.64 Today|||52-Week Range 4.24 | -49.06% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 28.9M | 20.4M | 4.5M | 44.5M | |
| Cost of Goods Sold | -- | -- | -- | 287.0K | ||
| Depreciation And Amortization | 1.4M | 941.0K | 465.0K | 594.0K | ||
| Operating Expenses | Gross Income | -- | -- | -- | 43.6M | |
| General Expenses | 79.2M | 83.4M | 83.6M | 116.3M | ||
| Research And Development | 62.8M | 63.4M | 46.3M | 46.9M | ||
| Total Operating Expenses | 80.6M | 84.4M | 84.1M | 117.2M | ||
| Non-Operating Expenses | Operating Income | -51.7M | -64.0M | -79.6M | -72.7M | |
| Extraordinary Charge | 0.00 | -5.8M | 0.00 | 0.00 | ||
| Other Expenses | 57.0K | 88.0K | 732.0K | 0.00 | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -51.5M | -69.2M | -78.0M | -70.5M | |
| Net Income | -51.5M | -69.2M | -78.0M | -70.5M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 88.4M | 94.4M | 126.3M | 160.5M | |
| Shares To Calculate EPS Diluted | 88.4M | 94.4M | 126.3M | 160.5M | ||
| Earnings Per Share | EPS | -$0.58 | -$0.73 | -$0.62 | -$0.44 | |
| EPS Diluted | -$0.58 | -$0.73 | -$0.62 | -$0.44 | ||
